Immunocytokines Market Report 2026

Immunocytokines Market Overview

• Immunocytokines market size has reached to $3.56 billion in 2025 • Expected to grow to $5.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Rising Prevalence Of Autoimmune Diseases Fueling The Growth Of The Market Due To Increasing Exposure To Environmental Pollutants And Growing Patient Population • Market Trend: Innovative Antibody-Cytokine Fusion Proteins Enable Targeted Cytokine Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunocytokines Market?

Immunocytokines refer to engineered fusion proteins that combine cytokines with antibodies or antibody fragments. Their primary purpose is to direct immune-stimulating cytokines specifically to target cells or tissues, enhancing the immune response against diseases such as cancer while minimizing systemic side effects. This targeted delivery enhances the therapeutic effects of cytokines while minimizing systemic toxicity. The main product types of immunocytokines are interleukins, interferons, tumor necrosis factors, and others. Interleukins refer to a group of cytokines, or signaling proteins, that are primarily produced by white blood cells and play a crucial role in regulating immune responses, inflammation, and the development of blood cells. Their mechanisms of action include antagonists, agonists, and immune modulators, and are used for various applications such as cancer, autoimmune diseases, infectious diseases, and others, serving end-users such as hospitals, research institutes, specialty clinics, and other end-users.

What Is The Immunocytokines Market Growth Forecast?

The immunocytokines market size is expected to see strong growth in the next few years. It will grow to $5.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to development of recombinant and modified interleukins, expansion of tumor necrosis factor-based immunocytokines, increasing investment in antibody-cytokine fusion proteins, rising adoption in personalized cancer and autoimmune therapy, integration of immune modulators with advanced delivery systems. Major trends in the forecast period include rising adoption of immunocytokines in targeted cancer therapies, growth in research on cytokine-based immunotherapies for autoimmune diseases, increasing focus on reducing systemic toxicity through targeted delivery, expansion of specialty clinics and research institutes using immunocytokines, development of fusion proteins combining cytokines with novel antibody formats.

Global Immunocytokines Market Segmentation

1) By Product Type: Interleukins, Interferons, Tumor Necrosis Factors, Other Product Types 2) By Mechanism Of Action: Antagonists, Agonists, Immune Modulators 3) By Application: Cancer, Autoimmune Diseases, Infectious Diseases, Other Applications 4) By End-User: Hospitals, Research Institutes, Specialty Clinics, Other End-Users Subsegments: 1) By Interleukins: Recombinant Interleukin, Modified Interleukin 2) By Interferons: Interferon Alpha, Interferon Beta, Interferon Gamma 3) By Tumor Necrosis Factors: Tumor Necrosis Factor Alpha, Tumor Necrosis Factor Beta, Tumor Necrosis Factor Receptor Fusion Proteins 4) By Other Product Types: Colony Stimulating Factors, Immunocytokines

What Is The Driver Of The Immunocytokines Market?

The rising prevalence of autoimmune diseases is expected to propel the growth of the immunocytokines market going forward. Autoimmune diseases refer to conditions in which the body’s immune system mistakenly attacks its own healthy cells and tissues. The growing prevalence of autoimmune diseases is primarily due to an increased exposure to environmental pollutants, which can disrupt immune function and trigger immune attacks on the body’s own tissues. Immunocytokines address autoimmune diseases by combining targeted immune modulation with precision delivery, making them ideal for minimizing systemic side effects. They enhance treatment effectiveness by directing cytokines specifically to affected tissues, improving patient outcomes and safety. For instance, in February 2024, according to the Arthritis Australia, an Australia-based non-profit organization, an estimated 562,378 Australians will be living with RA in 2025, accounting for 14% of all arthritis cases that year. By 2040, this number is expected to rise by 33% to 748,721 people. This represents an additional 186,343 Australians living with RA in 2040 compared with 2025. Therefore, the rising prevalence of autoimmune diseases is driving the growth of the immunocytokines industry.

Key Players In The Global Immunocytokines Market

Major companies operating in the immunocytokines market are Xencor Inc., Philogen S.p.A, Cytimmune Sciences Inc., Cytune Pharma S.A.S.

Global Immunocytokines Market Trends and Insights

Major companies operating in the immunocytokines market are focusing on developing innovative solutions, such as antibody cytokine fusion proteins, to enable targeted cytokine delivery and enhance therapeutic efficacy while minimizing systemic toxicity. Antibody cytokine fusion proteins are engineered molecules that combine the targeting ability of antibodies with the immune-modulating effects of cytokines to deliver therapy directly to diseased tissues, such as tumors or inflamed areas. For instance, in July 2023, SunHo BioPharmaceutical Co. Ltd., a China-based biopharmaceutical company, launched IBB0979 (B7H3–IL-10 immunocytokine), a novel antibody-cytokine fusion protein for the treatment of advanced or metastatic solid tumors, and has entered Phase I/II clinical trials. This innovative drug combines the tumor-targeting capabilities of the B7H3 antibody with the anti-inflammatory and immune-modulating effects of interleukin-10 (IL-10). IBB0979 is designed to modify the tumor microenvironment by delivering IL-10 specifically to B7H3-expressing tumor cells, reducing inflammation and boosting the immune response against cancer, potentially offering a new therapeutic approach for difficult-to-treat solid tumors.

What Are Latest Mergers And Acquisitions In The Immunocytokines Market?

In June 2023, Philogen S.p.A., an Italy-based biotechnology company, partnered with Merck & Co., Inc. (MSD) to advance clinical trials in oncology. With this partnership, Philogen and MSD aim to evaluate novel therapeutic candidates by combining Philogen’s tumor-targeted antibody-cytokine fusion proteins with MSD’s clinical development expertise, accelerating the generation of safety and efficacy data, optimizing patient selection, and supporting potential commercialization of next-generation cancer therapies. Merck & Co., Inc. (MSD) is a US-based pharmaceutical company that specializes in developing and commercializing innovative medicines and vaccines across oncology, infectious disease, and other therapeutic areas.

Regional Insights

North America was the largest region in the immunocytokines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immunocytokines Market?

The immunocytokines market consists of sales of body-cytokine fusion proteins, IL-2-based immunocytokines, and IL-12-based immunocytokines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immunocytokines Market Report 2026?

The immunocytokines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunocytokines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.